Marijuana Stock Movers For July 22, 2024

7/22/24 4:30:05 PM ET

Medicinal Chemicals and Botanical Products

Health Care

Medicinal Chemicals and Botanical Products

Health Care

Get the next $ACB alert in real time by email

GAINERS:

Leafbuyer Techs (OTC:LBUY) shares closed up 3900.00% at $0.02
Heritage Cannabis Holding (OTC:HERTF) shares closed up 125.00% at $0.00
AusCann Group Holdings (OTC:ACNNF) shares closed up 50.00% at $0.01
Cann Gr (OTC:CNGGF) shares closed up 37.50% at $0.02
Target Group (OTC:CBDY) shares closed up 30.59% at $0.00
Canopy Gwth (NASDAQ:CGC) shares closed up 17.25% at $8.35
RIV Capital (OTC:CNPOF) shares closed up 13.33% at $0.10
GrowGeneration (NASDAQ:GRWG) shares closed up 13.03% at $2.66
Auxly Cannabis Group (OTC:CBWTF) shares closed up 12.60% at $0.03
SNDL (NASDAQ:SNDL) shares closed up 9.66% at $2.27
Aurora Cannabis (NASDAQ:ACB) shares closed up 8.87% at $6.25
Village Farms Intl (NASDAQ:VFF) shares closed up 8.33% at $1.17
C21 Investments (OTC:CXXIF) shares closed up 8.20% at $0.26
OrganiGram Holdings (NASDAQ:OGI) shares closed up 7.88% at $1.77
Urban-gro (NASDAQ:UGRO) shares closed up 7.38% at $1.54
Green Thumb Industries (OTC:GTBIF) shares closed up 7.26% at $11.60
Body and Mind (OTC:BMMJ) shares closed up 7.21% at $0.03
Tilray Brands (NASDAQ:TLRY) shares closed up 6.70% at $1.92
Cresco Labs (OTC:CRLBF) shares closed up 5.20% at $1.74
Genetic Technologies (NASDAQ:GENE) shares closed up 4.35% at $0.78
Cronos Group (NASDAQ:CRON) shares closed up 4.20% at $2.49
Cipher Pharmaceuticals (OTC:CPHRF) shares closed up 3.65% at $6.67
CNBX Pharmaceuticals (OTC:CNBX) shares closed up 3.45% at $0.01

LOSERS:

Pharmadrug (OTC:LMLLF) shares closed down 31.25% at $0.01
1933 Industries (OTC:TGIFF) shares closed down 18.09% at $0.01
22nd Century Group (NASDAQ:XXII) shares closed down 9.87% at $0.74
iAnthus Capital Hldgs (OTC:ITHUF) shares closed down 9.47% at $0.02
Charlottes Web Holdings (OTC:CWBHF) shares closed down 9.09% at $0.17
Cansortium (OTC:CNTMF) shares closed down 6.00% at $0.14
CLS Holdings USA (OTC:CLSH) shares closed down 5.89% at $0.04
Mexco Energy (AMEX:MXC) shares closed down 5.53% at $11.00
Cannabix Technologies (OTC:BLOZF) shares closed down 5.20% at $0.41
4Front Ventures (OTC:FFNTF) shares closed down 3.30% at $0.10

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Get the next $ACB alert in real time by email

Crush Q1 2026 with the Best AI Superconnector

Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

AI-Powered Inbox

Context-aware email replies

Strategic Decision Support

Get Started with Standout.work

Recent Analyst Ratings for
$ACB
$CGC
$CRON
$GENE

Company	Date	Price Target	Rating	Analyst
Tilray Brands Inc. $TLRY	1/27/2026		Hold	Canaccord Genuity
Aurora Cannabis Inc. $ACB	1/27/2026		Buy	Canaccord Genuity
Organigram Global Inc. $OGI	1/27/2026		Buy	Canaccord Genuity
Cronos Group Inc. $CRON	1/27/2026		Buy	Canaccord Genuity
Canopy Growth Corporation $CGC	11/10/2025		Sell → Hold	The Benchmark Company
SNDL Inc. $SNDL	9/3/2025	$5.00	Buy	Alliance Global Partners
Aurora Cannabis Inc. $ACB	12/11/2024		Buy	TD Cowen
SNDL Inc. $SNDL	7/17/2024		Speculative Buy	Canaccord Genuity

More analyst ratings

$ACB
$CGC
$CRON
$GENE
Press Releases

Fastest customizable press release news feed in the world

Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand

NASDAQ | TSX: ACB Launch reinforces Aurora's leadership position across key international markets EDMONTON, AB, Feb. 11, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, is expanding its Aurora® medical portfolio in Australia and New Zealand, delivering patients and prescribers enhanced choice, reliable quality, and easier access to science-backed products. The expansion underscores the company's ongoing dedication to meeting the unique needs of patients and healthcare professionals in the region, reflecting Aurora's strategic focus on long-term global growth.

2/11/26 7:00:00 AM ET

Medicinal Chemicals and Botanical Products

Health Care

Mexco Energy Corporation Reports Financial Results for Third Quarter

MIDLAND, TX, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Mexco Energy Corporation (NYSE:MXC) today reported net income of $615,702, or $0.30 per diluted share, for the nine months ending December 31, 2025. For the third quarter of fiscal 2026, the Company reported net income of $50,245, or $0.02 per diluted share, a decrease of 89% when compared to $469,133, or $0.22 per diluted share, for the prior year quarter. This decrease is primarily due to the decline in oil prices. Operating revenues in the third quarter of fiscal 2026 were $1,383,887. For the nine months ended December 31, 2025, operating revenues were $4,932,806, a decrease of 8% when compared to the first nine months of fiscal 2025. Thi

2/10/26 5:00:00 PM ET

Oil & Gas Production

Energy

Organigram Reports First Quarter Fiscal 2026 Results

Strong year-over-year growth supported by Canadian leadership and growing international sales, improving gross margin. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 ("Q1 Fiscal 2026" or "Q1"). Q1 FISCAL 2026 HIGHLIGHTS Gross Revenue: $97.3 million (+46% year-over-year). Net Revenue: $63.5 million (+49% year-over-year). International Revenue: $5.0 million (+51% year-over-year). Adjusted EBITDA2: $5.3 million (+273% year-over-year). #1 Market Share in Canada: #1 in vapes, #1 in milled flower, #1 in concentrates, #2

2/10/26 6:00:00 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

$ACB
$CGC
$CRON
$GENE
Leadership Updates

Live Leadership Updates

Breckenridge Distillery Appoints Romano Beverage for Distribution in Illinois

BRECKENRIDGE, Colo., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand owned by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), has announced appointment of Romano Beverage, a respected partner, to manage distribution responsibilities within the state. Romano Beverage, a trusted leader in beverage distribution, is now overseeing Breckenridge Distillery's full spirits collection across Illinois—including its celebrated bourbon whiskey, whiskey, rum, vodka, gin, and newly launched Mountain Shot. Romano's strong presence in Illinois and dedication to exceptional service make them the perfect partner to help Breckenridge Distillery thr

2/4/26 8:00:00 AM ET

Medicinal Chemicals and Botanical Products

Health Care

Village Farms International Creates Global Strategy Officer Role and Appoints Brian Stevenson

Proven tobacco, pharmaceutical, and cannabis executive will lead the Company's enterprise-wide strategic agenda Appointment underscores the Company's commitment to disciplined global expansion and long-term value creation LAKE MARY, Fla., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ:VFF), today announced the appointment of Brian Stevenson to the role of Global Chief Strategy Officer. In this newly created role, Mr. Stevenson will lead the Company's enterprise-wide strategic agenda, including long-term growth strategy, global market assessment, and integration initiatives across regions and business units. Mr. Stevenson wil

12/17/25 4:30:00 PM ET

Canopy Growth to Acquire MTL Cannabis; Transaction Expected to Create Canada's Leading Medical Cannabis Business and Enhance Capacity to Serve Growing International Demand

This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024 All financial amounts in this press release are expressed in Canadian dollars. Highly accretive business combination expected to generate significant run-rate synergies of approximately $10 million within 18 months Strengthens Canopy Growth's presence in Québec with an opportunity to expand national distribution of MTL's high-quality, budtender-recommended product portfolio2 MTL's core management team is expected to join Canopy Growth to drive cultivation excellence and enhance the Company's p

12/15/25 7:00:00 AM ET

Medicinal Chemicals and Botanical Products

Health Care

$ACB
$CGC
$CRON
$GENE
Financials

Live finance-specific insights

Mexco Energy Corporation Reports Financial Results for Third Quarter

MIDLAND, TX, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Mexco Energy Corporation (NYSE:MXC) today reported net income of $615,702, or $0.30 per diluted share, for the nine months ending December 31, 2025. For the third quarter of fiscal 2026, the Company reported net income of $50,245, or $0.02 per diluted share, a decrease of 89% when compared to $469,133, or $0.22 per diluted share, for the prior year quarter. This decrease is primarily due to the decline in oil prices. Operating revenues in the third quarter of fiscal 2026 were $1,383,887. For the nine months ended December 31, 2025, operating revenues were $4,932,806, a decrease of 8% when compared to the first nine months of fiscal 2025. Thi

2/10/26 5:00:00 PM ET

Oil & Gas Production

Energy

Organigram Reports First Quarter Fiscal 2026 Results

Strong year-over-year growth supported by Canadian leadership and growing international sales, improving gross margin. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 ("Q1 Fiscal 2026" or "Q1"). Q1 FISCAL 2026 HIGHLIGHTS Gross Revenue: $97.3 million (+46% year-over-year). Net Revenue: $63.5 million (+49% year-over-year). International Revenue: $5.0 million (+51% year-over-year). Adjusted EBITDA2: $5.3 million (+273% year-over-year). #1 Market Share in Canada: #1 in vapes, #1 in milled flower, #1 in concentrates, #2

2/10/26 6:00:00 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Aurora Cannabis Announces Fiscal 2026 Third Quarter Results

NASDAQ | TSX: ACB Expands YoY Total Net Revenue1 by 7% to $94.2 million, with Global Medical Cannabis Net Revenue1 Increasing by 12% to a Record $76.2 millionDelivers Adjusted EBITDA1 of $18.5 million and Adjusted Net Income1 of $7.2 millionGenerates Free Cash Flow1 of $15.5 million Maintains Strong Balance Sheet with $154.4 million of Cash2 and Short-Term Investments, and a Debt-Free Cannabis Business2EDMONTON, AB, Feb. 4, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third quarter 2026 period ending December 31, 2025.

2/4/26 7:00:00 AM ET

Medicinal Chemicals and Botanical Products

Health Care